注射用重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白剂量递减方案与标准剂量维持方案治疗强直性脊柱炎的疗效比较
余海燕
Comparison of clinical effect between dose reduction scheme for hTNFR：Fc for injection and standard dose maintenance scheme in treatment of ankylosing spondylitis
YU Haiyan
广州医药
.
2019, (1): 12
-15
.
DOI: 10.3969/j.issn.1000-8535.2019.01.003
